Boncresa (denosumab-mobz)

**Product type:** Human Prescription Drug

**Active ingredient:** DENOSUMAB

**Strength:** 60 mg/mL

**Dosage form:** Injection, Solution

**Route:** Subcutaneous

**Labeler:** Amneal Pharmaceuticals LLC

**Marketing category:** BLA (BLA761456)

**Pharmacologic class:** RANK Ligand Blocking Activity [MoA], RANK Ligand Inhibitor [EPC]